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Photoacoustic (PA) computed tomography (PACT) beneﬁts from genetically encoded probes
with photochromic behavior, which dramatically increase detection sensitivity and speciﬁcity
through photoswitching and differential imaging. Starting with a DrBphP bacterial phyto-
chrome, we have engineered a near-infrared photochromic probe, DrBphP-PCM, which is
superior to the full-length RpBphP1 phytochrome previously used in differential PACT.
DrBphP-PCM has a smaller size, better folding, and higher photoswitching contrast. We have
imaged both DrBphP-PCM and RpBphP1 simultaneously on the basis of their unique signal
decay characteristics, using a reversibly switchable single-impulse panoramic PACT (RS-SIP-
PACT) with a single wavelength excitation. The simple structural organization of DrBphP-
PCM allows engineering a bimolecular PA complementation reporter, a split version of
DrBphP-PCM, termed DrSplit. DrSplit enables PA detection of protein–protein interactions in
deep-seated mouse tumors and livers, achieving 125-µm spatial resolution and 530-cell
sensitivity in vivo. The combination of RS-SIP-PACT with DrBphP-PCM and DrSplit holds
great potential for noninvasive multi-contrast deep-tissue functional imaging.
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To better understand the molecular mechanisms anddynamics involved in physiology and disease in a wholeorganism, biomedical studies increasingly employ non-
invasive whole-body imaging with high-resolution in vivo1–3.
Optical imaging offers valuable information and has been
widely used in such studies4,5. However, photons are strongly
scattered in biological tissue, limiting high-resolution pure optical
imaging to a penetration depth within the optical diffusion limit
(~1 mm)6. Photoacoustic (PA) computed tomography (PACT),
by acoustically detecting photons absorbed by tissue, breaks the
resolution and depth limitations of pure optical imaging and
provides high-resolution imaging with optical contrast at depths
up to centimeters7. PACT, highly sensitive to optical absorption
by molecules, is inherently suited for molecular imaging using
optically absorbing probes8–12.
Genetically encoded probes are advantageous due to their
harmless non-invasiveness, precisely controllable targeting, and
tissue-speciﬁc promoters. The combination of PACT and a
reversibly photoswitchable near-infrared (NIR) absorbing full-
length bacterial phytochrome (BphP) from Rhodopseudomonas
palustris, RpBphP1, has resulted in an advanced differential
imaging technique, termed reversibly switchable PACT (RS-
PACT). RS-PACT provided substantially enhanced detection
sensitivity in deep tissues13 in comparison with conventional
PACT. PACT is now widely used with various proteins exhibiting
reversible photochromic behavior14. Temporal unmixing has
been applied to separate signals from two photoswitchable
ﬂuorescent proteins (FPs) in tissue phantoms15,16, however, their
short absorption wavelengths make them less suited to deep-
tissue PA imaging. Dual wavelength excitation has also been
proposed to improve imaging sensitivity of BphPs, but is still
limited to detecting only one phytochrome in vivo17,18.
Structurally, BphP proteins consist of a photosensory core
module (PCM) and various so-called effector domains19–21
(Supplementary Fig. 1). The PCM is formed by the PAS (Per-
ARNT-Sim), GAF (cGMP phosphodiesterase/adenylate cyclase/
FhlA), and PHY (phytochrome-speciﬁc) protein domains con-
nected with α-helix linkers, and typically has a molecular weight
of 55–58 kDa. The spectral properties of BphPs are determined by
a covalently attached chromophore, biliverdin IXα (BV). BV is an
enzymatic product of heme and is widely present in mammalian
cells and tissues. Incorporation of BV by an apoform of the BphP
protein occurs in two steps. First, BV is secured to a
chromophore-binding pocket in the GAF domain, and second, a
covalent thioether bond is formed between the pyrrole ring A
(C32 atom) and the cysteine residues in the PAS domain22,23
(Supplementary Fig. 1). Canonical natural BphPs have two
absorbing states, one of which absorbs at 670–700 nm (the Pr
state) and the other at 740–780 nm (the Pfr state) (Fig. 1a). All
BphPs exhibit natural photochromic behavior: they undergo
reversible Pfr→ Pr photoswitching upon 730–790 nm light irra-
diation and Pr→ Pfr photoswitching upon 630–690 nm light
irradiation. Here, we term the Pfr state of the BphP-based probes
the ON state and the Pr state the OFF state.
The RpBphP1, used in RS-PACT, consists of the PCM and two
additional effector domains, named the PAS/PAC and HOS
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Fig. 1 Spectral and photoacoustic characterization of the DrBphP-PCM. aMolar extinction spectra of oxy-hemoglobin (HbO2), deoxy-hemoglobin (Hb), Pfr
(ON), and Pr (OFF) state of DrBphP-PCM and RpBphP1. b Schematic of the whole-body photoacoustic computed tomography (PACT) system with a ring-
shaped illumination pattern. BC beam combiner, CL conical lens, DAQ data acquisition unit, ED engineering diffuser, M mirror, OC optical condenser,
P prism, PC personal computer, pre-A pre-ampliﬁer, USTA ultrasonic transducer array. L1, a Ti:Sapphire laser ﬁred at 780 nm is used for PA imaging and
switching off BphPs. L2, the optical parametric oscillator (OPO) laser, ﬁred at 630 nm, switches BphPs ON. c Time sequence of photoswitching and imaging
of BphPs (pop., population). d Absorbance of DrBphP-PCM at 780 nm, switched OFF with 780 nm light illumination and then switched ON with 630 nm
illumination. The photoswitching period was 180 s for both wavelengths. e PA images of transparent silicone tubes ﬁlled with proteins in clear media. Left
column: ON state PA image of BphPs and hemoglobin, middle column: frequency lock-in reconstructed (LIR) PA image of BphPs and hemoglobin; right
column, decay constant encoded image showing a reliable separation of DrBphP-PCM, RpBphP1, and non-switchable hemoglobin. Scale bar, 500 µm. f PA
signal changes upon 780 nm light illumination and their ﬁts, where PA signals from either DrBphP-PCM or RpBphP1 exponentially decrease during
photoswitching, but with different decay constants. However, the blood signal remains at the original level. Thus, the difference in decay constants enables
a good separation of hemoglobin, DrBphP-PCM, and RpBphP1. g The switching ratio of BphPs and hemoglobin, deﬁned as the ratio between the ON and
OFF states of the PA amplitude, in both clear medium (0mm in depth) and scattering medium (12 mm in depth); error bars are s.e.m. (n= 40), calculated
based on the pixel values from regions of interest
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05231-3
2 NATURE COMMUNICATIONS |  (2018) 9:2734 | DOI: 10.1038/s41467-018-05231-3 | www.nature.com/naturecommunications
domains, and forms a dimer24. Moreover, the HOS domain of
one monomer interacts with the PCM of another monomer in the
dimer. Because of its high molecular weight of ~82 kDa, RpBphP1
exhibits a limited folding efﬁciency and low expression level in
mammalian cells. Attempts to delete the HOS domain resulted in
the loss of photochromic behavior, suggesting that HOS binding
to PCM is required for photoswitching. This ﬁnding was sur-
prising, because in some BphPs, deletion of the effector domains
does not affect reversible photoswitching, and only further
truncation of the PHY domain starts to impair it25,26. A PCM
part of the DrBphP phytochrome from Deinococcus radiodurans
(termed DrBphP-PCM below) does not interact with effector
domains, preserves photochromism without effector domains,
and is 1.5 times smaller than RpBphP127 (Supplementary Fig. 1).
These features make it an attractive template for engineering
advanced PA probes.
Currently, because of the absence of PA probes with NIR
absorbance, whole-body molecular imaging of protein–protein
interactions (PPIs) employs bioluminescent luciferases and FPs.
PPI studies utilize Förster resonance energy transfer (FRET),
bioluminescence energy transfer (BRET), and bimolecular ﬂuor-
escence complementation (BiFC) approaches. However, relatively
small changes in the FRET and BRET signals make these tech-
niques suboptimal for use in whole mammals. BiFC is based on
the tagging of two proteins of interest, each with half of an FP.
Upon interaction of the proteins, the two halves of the split FP
associate with each other to form a ﬂuorescent complex with the
complemented FP, thus reporting the PPIs. Recently, we engi-
neered several BiFC reporters from NIR FPs and demonstrated
their ability to detect PPIs in mice28,29. However, NIR BiFC did
not provide high spatial resolution and sensitivity in imaging PPIs
in deep tumors. PPIs were also imaged in vivo using split luci-
ferase30–33 and thymidine kinase34, resulting in bioluminescence
and positron emission signals, respectively. However, these
reporters require injection of substrates. Moreover, the emission
of the most red-shifted split luciferase is limited to 615 nm33, and
thymidine kinase’s signal provides low contrast and a non-
speciﬁc background in vivo.
Here, we report a PACT technique which combines three
approaches, namely single-impulse panoramic PACT (SIP-
PACT)2, RS-PACT13, and real-time detection of the photo-
switching rates of genetically encoded photochromic probes. We
term this combined technique RS-SIP-PACT. We also char-
acterize DrBphP-PCM both in vitro and in vivo as an advanced
NIR photochromic probe for PACT techniques and demonstrate
that it outperforms RpBphP1. We introduce both BphPs into the
same mammalian cells, resulting in a distinctive decay char-
acteristic in comparison with the cells expressing DrBphP-PCM
only. By discriminating the different decay characteristics, we
successfully separate both cell types in deep tissue. Using a single
illumination wavelength, we perform multi-contrast temporal
frequency lock-in PA reconstruction (LIR) of two different
tumors expressing the BphPs at depths in vivo. We next engineer
a split version of DrBphP-PCM, resulting in the ﬁrst bimolecular
photoacoustic complementation (BiPC) reporter, termed DrSplit,
and apply it to study intracellular PPIs in deep-seated mouse
tumors and livers in vivo.
Results
Design and characterization of RS-SIP-PACT system. To
characterize DrBphP-PCM as a PA probe and compare it with
RpBphP1, we upgraded SIP-PACT for real-time reversible pho-
toswitching, detection of photoswitching rates, and imaging,
creating RS-SIP-PACT, which provides 125 µm in-plane resolu-
tion and ~1mm elevational resolution (Supplementary Fig. 2). In
order to image RpBphP1, DrBphP-PCM proteins, and the DrSplit
reporter, we combined a Ti:Sapphire laser and an optical para-
metric oscillator (OPO) for illumination. These two lasers were
synchronized and triggered by an FPGA-based controller
(Methods). While the previous RS-PACT took 1.6 s to form a
cross-sectional image with eight times multiplexing13, RS-SIP-
PACT requires only 50 µs to acquire data for one frame with a
single laser pulse. Moreover, although its frame rate is
currently limited by the imaging laser’s repetition rate (20 Hz),
RS-SIP-PACT has achieved a 32-times greater frame rate than the
previous RS-PACT13. Due to the high-imaging speed of RS-SIP-
PACT, we are able to capture the entire photoswitching process
of the BphPs in real time, which enables temporal frequency
analysis on each pixel. The result is a better contrast-to-noise
ratio (CNR) in the images of BphPs, and a reduction in the
impacts of motion (e.g., from respiration and heart beating)
during in vivo imaging. In addition, the real-time detection of the
photoswitching rates of BphPs allows a good separation of
RpBphP1 and DrBphP-PCM, which have different photoswitch-
ing rates, using a single wavelength excitation.
Comparison of DrBphP-PCM and RpBphP1 as PA probes. We
ﬁrst measured the molar extinction coefﬁcients for the ON states
and the OFF states of DrBphP-PCM and RpBphP1. The ratios
between the extinction coefﬁcients of the ON state (Pfr form) at
780 nm and the OFF state (Pr form) at 630 nm of DrBphP-PCM
and RpBphP1 were 9.9 and 4.1, respectively (Fig. 1a and Sup-
plementary Fig. 3). We employed 780 nm light for PA imaging
and photoswitching the BphPs to the OFF state, and used 630 nm
light to switch the BphPs back to the ON state (Fig. 1b, c). The
laser ﬂuence on the sample surface at both wavelengths did not
exceed 12 mJ cm−2, which is below the American National
Standards Institute safety limit35. The imaging and photo-
switching time sequences are shown in Fig. 1c. The change in
RpBphP1 absorbance at 780 nm between the ON and OFF states
was about four times, similar to earlier observations13. The
changes in DrBphP-PCM absorbance at 780 nm between the ON
and OFF states were two times larger than that of RpBphP1
(Fig. 1d), which resulted in higher PA imaging contrast (Sup-
plementary Table 1).
Tubes ﬁlled with DrBphP-PCM (~30 µM), hemoglobin (bovine
blood with 90% oxygen saturation, sO2), and RpBphP1 (~30 µM),
respectively, were ﬁrst embedded in clear gelatin (Fig. 1e).
Although hemoglobin has the highest contrast in the ON state
images (Fig. 1e, left column), in LIR, where a pixel-wise extraction
of amplitudes of the harmonics of the illumination modulation
frequency, both DrBphP-PCM and RpBphP1 signals stand out
(Fig. 1e, middle column). The LIR method successfully separated
the PA signals from two BphPs from the non-photoswitchable
blood signals, even with 2.5 times higher CNR than previous
differential method13 (Methods and Supplementary Fig. 4).
Typically, a threshold level of four times the noise level, estimated
as the standard deviation of the background signal outside the
imaged region, was globally applied to the PA LIR images.
Compared to RpBphP1, DrBphP-PCM took about three times
longer time to photoswitch from the ON state to the OFF state
(Fig. 1f, Supplementary Fig. 3c–f, and Supplementary Table 1).
This photochemical feature enabled separating the PA signals of
DrBphP-PCM and RpBphP1 by measuring the signal decay
constants during imaging. Moreover, since hemoglobin is non-
photoswitchable, its decay constant was close to zero, making
it even more distinguishable from the BphP-based probes in
RS-SIP-PACT (Fig. 1e, right column). The ON-to-OFF photo-
switching rate (decay constant) here is deﬁned as the reciprocal
of the time it takes for the PA signal from the protein to drop to
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1/e of its maximum. The ON-to-OFF photoswitching rates of
DrBphP-PCM and RpBphP1 were 0.54 s–1 and 1.56 s–1, respec-
tively, as measured at a laser ﬂuence of 4 mJ cm–2 at 780 nm
(Supplementary Table 1).
We further compared the reversible photoswitching of both
BphPs in scattering media at depths using 780 nm illumination.
Tubes ﬁlled as before were embedded at a depth of 12 mm inside
a scattering medium (10% gelatin and 1% intralipid in distilled
water; reduced scattering coefﬁcient of ~10 cm−1)36. We deﬁned
the photoswitching ratio as the ratio of the measured PA signal
amplitude of BphPs in the ON state to that in the OFF state. In
both the clear medium (0 mm in depth) and scattering medium
(12 mm in depth), DrBphP-PCM exhibited two times better
photoswitching ratio than RpBphP1 (Fig. 1g).
Multi-contrast RS-SIP-PACT imaging in cells and in vivo. To
compare expression levels of DrBphP-PCM and RpBphP1 in
mammalian cells, we designed two similar plasmids where EGFP
was co-expressed through a self-cleavable T2A peptide after the
BphPs. The expression from these plasmids resulted in equimolar
levels of a BphP and an EGFP control. Flow cytometry of HeLa
cells transfected with these plasmids showed that the DrBphP-
PCM expression level was 2.3 times higher than that of RpBphP1
(Supplementary Fig. 5a, b), likely because of the 1.5 times smaller
size and simpler structural organization of the DrBphP-PCM,
which enabled faster protein folding at 37 °C in mammalian cells.
We next used RS-SIP-PACT to image U87 glioblastoma cells
stably expressing either RpBphP1 or DrBphP-PCM. With the RS-
SIP-PACT system, we imaged pure bovine blood and either
RpBphP1 or DrBphP-PCM expressing U87 cells embedded in
gelatin (Fig. 2a, Supplementary Fig. 5c, and Supplementary
Movie 1). The decay constants from the ON to the OFF state
enabled good separation of the blood and both types of U87 cells
(Fig. 2b–d and Supplementary Fig. 5d).
Blood and U87 mammalian cells were then embedded 15mm
deep in a scattering medium with a reduced scattering coefﬁcient of
~10 cm−1. We imaged the cells for ten photoswitching cycles, each
cycle containing 80 frames, and selectively distinguished the PA
signals from BphPs by using LIR (Methods). U87 cells expressing
DrBphP-PCM had CNRs of 176.7 ± 6.8 in the clear medium and
48.4 ± 3.6 in the scattering medium. However, U87 cells expressing
RpBphP1 had lower CNRs of 56.9 ± 5.8 and 14.0 ± 1.5, respectively
(Fig. 2e). The higher DrBphP-PCM expression level, together with
the higher absorbance ratio between the photoswitching states,
resulted in a three–four times enhancement of CNR for DrBphP-
PCM over that of RpBphP1 in the cultured mammalian cells.
Moreover, in comparison to previous differential imaging techni-
que, LIR provided an approximately two–three times improvement
in CNR (Supplementary Fig. 6). Thus, the combination of
the DrBphP-PCM and LIR algorithm enabled a ~10 times
(=3–4 × 2–3) CNR enhancement over the combination of
RpBphP1 and differential imaging, in total (Supplementary Fig. 6).
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Fig. 2 Photoacoustic characterization of the BphPs in cultured cells. a LIR image of bovine blood, U87 cells expressing either RpBphP1 or DrBphP-PCM.
Scale bar, 2 mm. b PA signal decays and their ﬁts from bovine blood, U87 cells expressing either RpBphP1 or DrBphP-PCM during 780 nm light illumination.
c Decay constant encoded image showing different photoswitching rates of U87 cells expressing either RpBphP1 or DrBphP-PCM and the non-switchable
bovine blood. Scale bar, 2 mm. d The computed decay constants of the three types of cells; error bars are s.e.m. (n= 40), calculated based on the pixel
values from regions of interest. e The contrast-to-noise ratio (CNR) of LIR signals from bovine blood and from U87 cells expressing either RpBphP1 or
DrBphP-PCM in a clear medium (0mm in depth) and a scattering medium (15mm in depth). f PA signal decays and their ﬁts for the two types of cells—
HEK-293 cells expressing both DrBphP-PCM and RpBphP1, and U87 cells expressing only DrBphP-PCM—under different illumination ﬂuences. g LIR
images (top row) of U87 cells (left) and HEK-293 cells (right) and the images of computed coefﬁcients of b (middle row) and c (bottom row) under
different illumination ﬂuences. The signal decays can be modeled in the form of gðtÞ ¼ aþ b  eðtT1Þ þ c  eðtT2Þ, where T1 > T2. The signals from HEK-293 cells
were ﬁtted with two similar coefﬁcients b≈ c≈ 0.5, while the signals from U87 cells were ﬁtted with very different coefﬁcients b≈ 1, c≈ 0. Scale bar, 2 mm.
h The computed coefﬁcients k, deﬁned as k ¼ maxfb;cgminfb;cg, under different light ﬂuences, showing a reliable separation of the two types of cells in
f, g. Independent of the light ﬂuence, the coefﬁcient k for HEK-293 cells is ~1, and the coefﬁcient k for U87 cells is much larger (>10); error bars are s.e.m.
(n= 120), calculated based on the pixel values from regions of interest
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The decay constants of the photoswitching processes depend
on the local ﬂuence. Under similar light ﬂuence, DrBphP-PCM
has a longer decay time than RpBphP1. However, due to optical
absorption and scattering, the local optical energy delivery per
unit area is unknown inside deep tissue, which poses a substantial
challenge to unmixing multiple contrasts at depths using their
decay constants. To address the unknown local optical ﬂuence, we
proposed a labeling strategy where we introduced both DrBphP-
PCM and RpBphP1 into the same HEK-293 mammalian cells and
introduced DrBphP-PCM only into U87 cells. Thus, the HEK-293
cells exhibited a distinctive decay characteristic in comparison
with the U87 cells.
We used RS-SIP-PACT to image the HEK-293 cells expressing
both BphPs in equimolar quantities from a single plasmid
(Methods) and the U87 cells expressing only DrBphP-PCM. For
each measurement voxel, we reasonably assumed that the local
ﬂuence was uniform within that voxel, because the 1/e optical
penetration depth for NIR light is far greater than the voxel
length. Experimental results showed that the photoswitching
signals from HEK-293 cells expressing both BphPs contained two
decay components, while the signals from U87 cells expressing
DrBphP-PCM exhibited only one decay component, regardless of
local ﬂuence (Fig. 2f, Supplementary Fig. 7a–d, and Supplemen-
tary Table 2). With this labeling strategy, we took advantage of
the number of decay components involved in the decay process to
reliably separate two types of cells, instead of relying on the decay
rates.
We modeled the decay process as a linear combination of two
single exponential decay functions with different decay constants
(Methods). By comparing the contributions of both decay
functions to the overall decay, we established a criterion: If the
contribution from the slower decay process is signiﬁcantly larger
(10×) than that from the faster decay process, the decay process is
dominated by one component and the signals are from U87 cells;
if the two contributions are similar (a ratio of ~1), the number of
decay components is two and the signals are from HEK-293 cells.
Therefore, by computing the number of decay components
involved in the decay process, we can reliably separate the two
types of cells in deep tissue, where knowledge of local ﬂuence is
limited (Fig. 2g, h, Supplementary Fig. 7e, and Supplementary
Table 2). If the HEK-293 and U87 cells are mixed together and
cannot be spatially resolved, we can quantify the concentration of
each cell type by comparing the contributions from the two decay
functions (Methods, Supplementary Fig. 7f, and Supplementary
Table 2).
To study the performance of DrBphP-PCM in vivo, we ﬁrst
injected 1 × 106 U87 cells expressing DrBphP-PCM into a mouse
brain and successfully detected the tumors using RS-SIP-PACT
(Supplementary Fig. 8). To demonstrate the advantages of
DrBphP-PCM in vivo, we imaged a mouse 2 weeks after injection
of 1 × 106 U87 cells expressing DrBphP-PCM into the left front of
the brain and 1 × 106 U87 cells expressing RpBphP1 into the right
rear of the brain. A conventional PACT image reveals the brain’s
cortical vasculature (Fig. 3a). In addition, LIR of ten
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Fig. 3 Multi-contrast PA imaging of BphPs in the mouse brain in vivo. a Conventional PA image of the tumor-bearing mouse brain cortex vasculature (ON
state). Approximately 1 × 106 U87 cells expressing DrBphP-PCM were injected into the left front of the brain, ~1 × 106 U87 cells expressing RpBphP1 were
injected into the right rear of the brain. The tumors are invisible in the ON state images due to the overwhelming background signals from blood. Scale bar,
2 mm. b LIR image overlaid on the mouse brain cortex vasculature, highlighting the two tumors of U87 cells expressing either RpBphP1 or DrBphP-PCM.
The overlay image shows the BphP signals in color and the background blood signals in gray. c PA signals from two tumors were modulated at the same
frequency by the illumination but with different signal decay constants. d Temporal frequency spectra of the PA signals from brain tumors and the cortical
arteries, showing both the harmonics of the illumination modulation frequency and the heartbeat frequency from the arteries. e PA signal decays and their
ﬁts for the two tumors expressing either DrBphP-PCM or RpBphP1. f The computed decay constants of the two tumors; error bars are s.e.m. (n= 160),
calculated based on the pixel values from regions of interest. g Decay constant encoded image illustrating good separation of the two tumors. Scale bar, 2
mm. h Decay constant encoded image overlaid on the mouse brain cortical vasculature, showing reliable separation of two tumors
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photoswitching cycles of conventional PACT images (each cycle
containing 80 frames) highlights the two U87 tumors (overlaid on
the cortex vasculature, Fig. 3b). We cannot directly separate the
DrBphP-PCM tumor from the RpBphP1 tumor, because the two
tumors have the same modulation frequency (Fig. 3c, d). Because
the tumors were seated beneath the scalp tissue, the local ﬂuence
values at the two tumors were comparable. We thus could
separate them by directly comparing their decay constants
(Fig. 3e–h and Supplementary Movie 2). We also demonstrated
this separation in peripheral regions of mouse kidneys (Fig. 4 and
Supplementary Movie 3). After PA imaging, we conﬁrmed the
tumors histologically (Fig. 4c)
The previous RS-PACT system required 1.6 s to form a cross-
sectional image, which blurred whole-body images due to
respiratory motion during data acquisition and thus reduced
the detection sensitivity. In comparison, RS-SIP-PACT takes just
50 µs to form a cross-sectional image, with completely negligible
motion artifacts. By taking advantage of this real-time imaging
capability, RS-SIP-PACT can image the decays of both BphPs
while monitoring the respiratory motion. Thus, LIR can highlight
the tumors, with minimized motion artifacts and high contrast
(Fig. 4a, f, g).
To reliably separate the two types of tumors inside deep tissue
in vivo, we applied the same labeling strategy to mouse liver
tumors. We ﬁrst injected U87 cells expressing DrBphP-PCM
(0.5 × 106) into the right lobe of the mouse liver and waited 5 days
to allow the injected U87 cells to grow. After the waiting period,
we injected HEK-293 cells expressing both BphPs (8 × 106) into
the left lobe of the liver. At 2 h post injection, we then imaged the
tumor-bearing mouse (n= 3) for 20 photoswitching cycles, each
of which contained 160 frames. The LIR image clearly resolved
the two tumors, with minimized motion artifacts (Fig. 5a). The
HEK-293 tumors contain two different photochromic proteins,
exhibiting two different decay constants in the decay process
(Fig. 5b, c); while the U87 tumors contain only one photochromic
protein, exhibiting only one decay constant in the decay process
(Fig. 5b, c). Moreover, by analyzing the number of decay
constants involved, we achieved reliable differentiation between
the two tumors in deep tissue (~9.1 mm beneath skin, Fig. 5d–f).
Characterization of DrSplit for protein–protein interaction.
We next designed a BiPC reporter from DrBphP-PCM. For this,
we genetically separated (split) DrBphP-PCM between the DrPAS
domain and the DrGAF-PHY domains, and termed the set of
these two constructs DrSplit (Fig. 6a). Notably, the PAS-GAF
domains alone do not exhibit reversible photoswitching37.
Complementation of the PAS domain with the GAF-PHY
domain reconstitutes the complete PCM (i.e., PAS-GAF-PHY
domains), thus recovering its photoswitching property. To test
DrSplit complementation, we used a rapamycin-induced PPIs
between the FRB and FKBP proteins28,29. We genetically fused
the FRB protein to the DrPAS domain, and the FKBP protein to
the DrGAF-PHY domains (Fig. 6b).
PA
 a
m
pl
itu
de
0
Max
0 1
Norm. decay constants
0.01 0.85
0 1
Tumor
Tumor
Left kidney
Right kidney
Breathing frequency
and harmonics
Modulated frequency
and harmonics of BphPs
a b c d
e f g
Time (s)
0 1 2 3 4
0
0.2
0.4
0.6
0.8
1
RpBphP1 fit
DrBphP-PCM fit
RpBphP1
DrBphP-PCM
Frequency (Hz)
N
or
m
al
iz
ed
 a
m
pl
itu
de
0 0.5 1 1.5 2
Breathing motion influenced region
Region of tumors
0
0.2
0.4
0.6
0.8
1
0.0
0.5
1.0
1.5
2.0
RpBphP1 DrBphP-PCM
0
20
40
60
80
100 Differential imaging LIR
Norm. lock-in amplitude
D
ec
ay
 c
on
st
an
ts
 (s
–
1 )
Rp
Bp
hp
1
Dr
Bp
hP
-PC
M
N
or
m
al
iz
ed
 P
A 
am
pl
itu
de
Co
nt
ra
st
-to
-n
oi
se
 ra
tio
Fig. 4 In vivo lock-in reconstruction of BphPs in kidneys and their decay analysis. a LIR image overlaid on a conventional PACT cross-sectional image by
780 nm illumination, highlighting the two tumors of U87 cells expressing either RpBphP1 (right side) or DrBphP-PCM (left side) on the two kidneys. The
overlay image shows the BphPs signal in color and the background blood signal in gray. b Decay constant encoded image overlaid on a conventional PACT
cross-sectional image made by 780 nm illumination. The LIR image was used to form a binary mask, and the decay constant computation was implemented
in the masked regions. c Representative H&E histological images of the two isolated kidneys, showing the tumors (bordered by green lines) corresponding
to a and b. Scale bar, 1 mm. d The computed decay constants of the two tumors. e PA signal decays and their ﬁts in the tumor regions. f Temporal
frequency spectra of the PA signals in the kidney tumors and the internal organs, showing both the harmonics of the illumination modulation frequency and
the harmonics of the respiratory frequency. g The LIR method provides approximately two–threefold better CNR of tumor cells expressing either DrBphP-
PCM or RpBphP1 than the differential imaging method; error bars are s.e.m. (n= 80), calculated based on the pixel values from regions of interest. Scale
bar, 5 mm
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Because the main application of DrSplit was foreseen as
in vivo imaging (see below), we made MTLn3 breast adeno-
carcinoma cells stably co-expressing DrPAS-FRB and FKBP-
DrGAF-PHY fusions and studied their complementation
using RS-SIP-PACT. Upon addition of rapamycin to the cells,
a BiPC occurred, reconstituting the functional DrBphP-PCM
(Fig. 7a–c). Complemented DrSplit retained 36% of the Pr state
ﬂuorescence of the non-split DrBphP-PCM (Supplementary
Fig. 9a) and almost 100% of Pr↔ Pfr photoswitching contrast
measured by changes of intrinsic ﬂuorescence (Fig. 7d, e). And
the Pr↔ Pfr photoswitching contrast measured by PA is retained
~50% (Supplementary Fig. 9b–d). DrSplit photoswitching at 780
nm was practically non-detectable without rapamycin, but was
restored after FRB-FKBP binding induced by rapamycin, thus
providing four times contrast (Supplementary Fig. 9d). The
CNRs of the LIR images in the absence or presence of rapamycin
were ~0.1 and 8.2, representing an ~82 times change in the CNRs
of LIR images upon PPI induction (Fig. 7f). Complemented
DrSplit in MTLn3 cells exhibited photoswitching ratios of 4.46 ±
0.49 in the clear medium and 2.60 ± 0.34 in the scattering
medium (Fig. 7g, h). We then analyzed the expression of DrSplit
in HeLa and U87 cells, and found that we could detect the
ﬂuorescence of EGFP co-expressed with DrPAS-FRB and
mCherry co-expressed with FKRB-DrGAF-PHY, even 72 h after
the transfection, indicating a low cytotoxity of the DrSplit
(Supplementary Fig. 10).
We have also demonstrated DrSplit’s application for micro-
scopic imaging (Supplementary Fig. 11). MTLn3 cells, stably
expressing DrPAS-FRB with EGFP and FKRB-DrGAF-PHY with
mCherry, exhibited ﬂuorescence of co-expressed ﬂuorescent
proteins in the absence of rapamycin. Upon induction of PPIs
with rapamycin, we detected weak intrinsic NIR ﬂuorescence of
the DrBphP-PCM reconstituted from DrSplit (Supplementary
Fig. 11a, b). The complementation of the DrSplit reporter
provided approximately ten-time stronger ﬂuorescence in the
NIR channel (Supplementary Fig. 11c). Thus, DrSplit can be used
as a multimodal reporter not only for BiPC, but also for BiFC.
RS-SIP-PACT imaging of PPIs in vivo with DrSplit. Using
DrSplit and RS-SIP-PACT, we next longitudinally imaged PPIs in
the tumors and monitored tumor metastases in the liver of mice
(n= 4) (Fig. 8a–d, Supplementary Fig. 12, and Supplementary
Movie 4). DrSplit-expressing MTLn3 cells (1 × 106) were ﬁrst
locally injected in the mouse liver. Then, rapamycin was injected
through the tail vein ~40–44 h before the PA imaging. The LIR
PA images highlighted the photoswitchable signals from the
complemented DrSplit resulting from the PPIs. We detected
exponential growth of the primary tumor in the right lobe of the
liver over 1 month (Fig. 8a–e). From day 15, we detected a
delayed exponential growth of secondary tumors on the left lobe
of the liver, resulted from metastasizing MTLn3 cells spreading to
the other liver lobe (Fig. 8b–e). The diameter of the secondary
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Fig. 5 In vivo separation of two types of cells at depths. The PA excitation wavelength was 780 nm. a LIR image overlaid on a conventional PACT cross-
sectional image by 780 nm illumination, highlighting the two tumors of HEK-293 cells expressing both DrBphP-PCM and RpBphP1 (left lobe) or U87 cells
expressing DrBphP-PCM (right lobe) inside the liver (n= 3). The overlay image shows the BphP signals in color and the background blood signals in gray.
b Coefﬁcient b encoded image overlaid on a conventional PACT cross-sectional image. The computed coefﬁcient, b, is shown in color, and the background
anatomy is shown in gray. The LIR image in a was used to form a binary mask, and the decay analysis was implemented in the masked regions.
c Coefﬁcient c encoded image overlaid on a conventional PACT cross-sectional image. The computed coefﬁcient, c, is shown in color, and the background
anatomy is shown in gray. d Normalized coefﬁcient k encoded image overlaid on a conventional PACT cross-sectional image. Because the HEK-293 tumors
contain two different photochromic proteins and U87 tumors contain only one photochromic protein, the normalized coefﬁcient k of HEK-293 tumors is
much smaller than that of U87 tumor, showing a reliable separation of the two tumors. The LIR image was used to form a binary mask, and the decay
constant computation was implemented in the masked regions. e PA signal decays and their ﬁts in the tumor regions. f The computed coefﬁcients of b, c,
and k from the tumor regions, where k, showing the largest difference, can be used to separate the two types of tumors. Independent of the light ﬂuence,
the coefﬁcient k for HEK-293 tumors is ~1, and the coefﬁcient k for U87 tumors is much larger (>8); error bars are s.e.m. (n= 140), calculated based on the
pixel values from regions of interest. Scale bar, 5 mm
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tumor on day 15 was ~400 µm (Fig. 8b). The postmortem his-
tology results conﬁrmed the PA-measured relative locations of
the tumors (Fig. 8f). The smallest secondary tumor had a dia-
meter of ~400 µm, assuming that the mean volume of MTLn3
cells is ~2000 µm3, each resolution voxel of the secondary tumor
contained ~3100 MTLn3 cells. The CNR of the secondary tumor
was ~9.7 in the LIR image. At a detection conﬁdence level of 90%,
corresponding to a CNR threshold of 1.65, we can detect PPIs
with as few as ~530 cells at this depth. We have also demon-
strated an application of DrSplit as BiFC reporter at depths
in vivo (Supplementary Fig. 13). We detected the ﬂuorescence of
reconstituted DrSplit after 32 days of tumor growth upon the
induction of PPIs with rapamycin.
We next compared non-split DrBphP-PCM and DrSplit in
native mouse tissues, without MTLn3 cell transplantation. We
ﬁrst performed hydrodynamic transfection38 of the plasmid
encoding DrBphP-PCM into the liver of mice (n= 4) (Supple-
mentary Figs. 14 and 15). Using RS-SIP-PACT, we found
signiﬁcant changes in the PA signals in the liver-expressing
DrBphP-PCM. We then hydrodynamically co-transfected mice
with DrPAS-FRB and FKBP-DrGAF-PHY plasmids encoding the
DrSplit reporter. As a baseline image, we imaged the mouse liver
after 24 h (Fig. 9a). To induce the PPIs resulting in the DrSplit
complementation, rapamycin was injected through the tail vein,
and the PA signals were detected ~42 h later (~66 h after
hydrodynamic injection) (Fig. 9b). Ex vivo PA imaging of the
isolated liver from the rapamycin-injected mouse further
conﬁrmed the reconstitution of functional DrBphP-PCM from
DrSplit (Fig. 9c–f), and the differential ﬂuorescence images also
validated the existence of reconstituted DrSplit (Supplementary
Fig. 16). The CNRs of the photoswitchable signals in the mouse
liver were 0.152 and 6.60 before and after the rapamycin
injection, respectively, indicating the ~43 times CNR enhance-
ment resulted from the induced PPIs (Fig. 9g). Upon rapamycin
injection, we observed a signiﬁcant increase of the LIR PA signals,
which indicated that PPIs had occurred in the liver tissue,
whereas vehicle injection alone did not cause any PA signal
changes (Fig. 9g).
Discussion
PACT is well suited to take maximum advantage of the photo-
chromic behavior of genetically encoded probes. Temporal
unmixing for the detection of photoswitchable ﬂuorescent pro-
teins has been demonstrated previously15,16. Recently, a BphP
from Agrobacterium tumefacience, called Agp117,18, was applied
for PA imaging in the same manner as RpBphP1 in earlier
reported RS-PACT13. Here, we combined the advanced RS-SIP-
PACT technique with two distinct BphP-based probes, DrBphP-
PCM and RpBphP1, which enabled multi-contrast PA in vivo
imaging with a single 780 nm excitation. We then designed the
ﬁrst BiPC reporter, DrSplit, and by combining it with RS-SIP-
PACT, photoacoustically detected PPIs with high spatial resolu-
tion in deep tissues at the whole-body level in mice. These
advances resulted from the photochemical and structural features
of DrBphP-PCM, which are superior to those of the previously
used RpBphP1, as well as from the high-imaging speed and the
LIR approach of RS-SIP-PACT, which provided high-sensitivity,
high-resolution imaging at depths beyond those achievable by
pure optical imaging39.
DrBphP-PCM is two times smaller than RpBphP1 and free
from interactions between the domains, which facilitates folding
and results in its higher expression in mammalian cells. These
beneﬁcial differences do not affect cell properties and allow
establishing cell lines that stably express DrBphP-PCM. Like
RpBphP1, DrBphP-PCM has OFF and ON states in the far-red
and NIR regions, where tissues have relatively low-light
attenuation, and therefore can maintain its photoswitching efﬁ-
ciency at depths. Further, DrBphP-PCM exhibits a two times
greater absorbance photoswitching ratio than RpBphP113. In our
experiments, the combination of all these characteristics provided
about four times enhancement of the image CNR at depths
in vivo. This performance makes DrBphP-PCM the reporter of
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choice for switching-contrast PACT techniques, such as RS-
PACT and the advanced RS-SIP-PACT reported here.
Both DrBphP-PCM and RpBphP1 are photochromic and share
similar absorption spectra in the ON and OFF states, so it is
not possible to discriminate between these BphPs using standard
multi-wavelength unmixing or differential imaging methods.
However, DrBphP-PCM has a three-time lower photoswitching
rate from the ON to the OFF state than RpBphP1, which
requires a longer imaging time to capture the photoswitching
process. Considering the unknown ﬂuence, we proposed a
labeling strategy where the HEK-293 cells were labeled with both
DrBphP-PCM and RpBphP1 in equimolar quantities and U87
cells were labeled with DrBphP-PCM only. By computing the
number of decay components involved in the photoswitching
process, we successfully separated the two types of cells in deep
tissue—a task that, due to unknown local ﬂuence, cannot be
reliably done by either the previous RS-PACT13 or other tem-
poral unmixing methods15,16. Thus, RS-SIP-PACT not only
increases the CNR of images by selectively highlighting the
photoswitching components using LIR, but also separately detects
several spectrally similar photochromic probes based on their
unique decay characteristics. Unlike spectral unmixing-based
probe separation approaches, probe discrimination based on
decay characteristics should allow simultaneous imaging of a
substantially larger number of different cells expressing properly
designed BphP-derived photochromic probes, using a single
wavelength excitation. More importantly, the combination of the
decay analysis and the protein development has successfully
addressed the impact of unknown local ﬂuence and enabled
multi-contrast imaging at depths.
The smaller size and simpler domain interaction in DrBphP-
PCM allowed us to design the DrSplit reporter, enabling the BiPC
technique to detect PPIs photoacoustically. Compared to the
similar, but purely optical, BiFC technique, BiPC provides deeper
PPI detection with higher resolution. The BiPC technique
introduced here enabled PPI detection in a whole animal with as
few as 530 secondary tumor cells. DrSplit, designed in this work,
retains most of the advantageous photochromic and PA
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Fig. 7 PA characterization of DrSplit in mammalian cells. a ON state PA image of MTLn3 cells expressing DrSplit (left) and MTLn3 cells expressing DrSplit
in the presence of rapamycin (right). Scale bar, 2 mm. b OFF state PA image of MTLn3 cells expressing DrSplit (left) and MTLn3 cells expressing DrSplit in
the presence of rapamycin (right). c LIR PA image of MTLn3 cells expressing DrSplit (left) and MTLn3 cells expressing DrSplit in the presence of rapamycin
(right). The induction with rapamycin reconstitutes the functional DrBphP-PCM, which responds to the periodical light modulation. d Repeated
ﬂuorescence changes of the lysate of HeLa cells expressing DrBphP-PCM detected at 720 nm during recurrent illumination cycles with 780/20 nm and
636/20 nm. e Repeated ﬂuorescence changes of the lysate of HeLa cells expressing DrSplit in the presence (black line) or absence (blue line) of
rapamycin, detected at 720 nm during recurrent illumination cycles with 780/20 nm and 636/20 nm. f MTLn3 cells expressing DrSplit and MTLn3 cells
expressing DrSplit in the presence of rapamycin and blood (dilute 10×) show similar CNRs in the ON state PA image; while the LIR image shows an
outstanding CNR for MTLn3 cells expressing DrSplit in the presence of rapamycin. g LIR image of blood and MTLn3 cells expressing DrSplit in the presence
of rapamycin in a clear medium (0mm in depth) and a scattering medium (15mm in depth). Scale bar, 2 mm. h The switching ratio of blood and MTLn3
cells expressing DrSplit in the presence of rapamycin in both a clear medium (0mm in depth) and a scattering medium (15 mm in depth); error bars are
s.e.m. (n= 40), calculated based on the pixel values from regions of interest. Rapa is short for rapamycin
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05231-3 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2734 | DOI: 10.1038/s41467-018-05231-3 |www.nature.com/naturecommunications 9
properties of the parental DrBphP-PCM. Therefore, the BiPC
approach should allow simultaneous detection of several PPIs by
using multiple BphP-derived split probes that exhibit different
ON-to-OFF photoswitching rates. Moreover, unlike BiFC,
detection of several PPIs using BiPC can be performed with a
single excitation wavelength. Further application of the DrSplit
reporter could be simpliﬁed by using a self-cleavable peptide,
such as T2A, inserted between the DrBphP-PAS and DrBphP-
GAF-PHY parts, allowing co-expression of the complete BiPC
reporter from a single plasmid.
In turn, the developed RS-SIP-PACT technique, no longer
requiring data multiplexing, substantially accelerates the PA
imaging process and further improves the detection sensitivity. In
addition, the LIR method is simple and reliable; the background
signals and respiratory motion inﬂuence are removed without
loss of spatial resolution and sensitivity.
The NIR photochromic DrBphP-PCM probe and DrSplit PPI
reporter engineered here, combined with RS-SIP-PACT, open
possibilities in basic biology and biomedical research. Both
probes can noninvasively monitor individual pathways in
subsets of cells in deep tissue and provide analysis of multiple
pathways in a whole organ. DrSplit will allow detection of
various biological processes that involve PPIs, such as wound
healing, host–pathogen interactions, and organ development,
and also serve as a whole-cell sensor for metabolic changes.
Although BiPC of split reporters, such as DrSplit, can be irre-
versible, as with BiFC, it will visualize the accumulation of
transient PPIs and low-afﬁnity complexes40,41. The higher-
detection sensitivity of BiPC can advance the monitoring of
activities of drug targets, to identify potential off-target effects
by detecting PPIs associated with downstream pathways. Fur-
thermore, it will enable in vivo genome-wide studies of PPIs,
which previously were tested with BiFC, outperforming it in
depth and spatial resolution42.
Methods
Photoacoustic tomography. In PAT, as photons propagate in tissue, some are
absorbed by biomolecules and their energy is partially or completely converted into
heat. The heat-induced pressure propagates in the tissue and is detected outside the
tissue by an ultrasonic transducer or transducer array to form an image that maps
the original optical energy deposition in the tissue. The scattering of acoustic waves,
within the ultrasonic frequency range of interest, is about three orders of magni-
tude weaker than that of light in soft tissue, on a per unit path length basis, which
means that PAT can provide high spatial resolution at depths reachable by diffuse
photons. PACT is a major implementation of PAT. A multi-element ultrasonic
transducer array, or a mechanical/electronic scanning equivalent, is used to detect
photoacoustic waves. Then, an inverse algorithm—essentially a method for accu-
rately locating photoacoustic sources and mapping the absorbed optical energy
density from the time-resolved acoustic signals—is employed to reconstruct high-
resolution images.
Plasmid construction. The DrBphP gene was kindly provided by J. Ihalainen
(University of Jyväskylä, Finland). The RpBphP1 gene was kindly provided by
E. Giraud (Institute for Research and Development, France). For mammalian
expression, the RpBphP1 gene was cloned as described earlier13. PCM part
encodings of the ﬁrst 502 amino acids of DrBphP gene were PCR ampliﬁed as a
NheI-KpnI fragment and cloned into the pAcGFP1-Hyg-N1 plasmid (Takara/
Clontech). The AcGFP1 gene was cut out using BamHI and NotI enzymes and
swapped with IRES2-mCherry, which was a fragment of the pIRES2-mCherry
plasmid (Takara/Clontech). The ﬁnal pIRES2-mCherry-DrBphP-PCM plasmid
bears the Hygromycin resistance. The resulting plasmid allows co-expression of
DrBphP-PCM and mCherry proteins from the same bicistronic mRNA. For
equimolar mammalian expression from individual plasmids, the RpBphP1 gene or
the PCM part of the DrBphP gene were PCR ampliﬁed as BglII-AscI fragments and
cloned into multi-cloning sites of the pMCS-T2A-EGFP vector developed in our
laboratory. The resulting plasmids allowed equimolar co-expression of RpBphP1 or
DrBphP-PCM and EGFP proteins. To obtain plasmid for equimolar expression of
both BphPs in one mammalian cell, the PCM part of the DrBphP gene was
ampliﬁed via PCR as SpeI-NotI fragment and cloned into the RpBphP1-T2A-EGFP
plasmid instead of EGFP gene.
For mammalian expression of DrSplit, the DrPAS encoding DNA fragment was
PCR ampliﬁed as an XbaI-XbaI fragment and cloned into the iSPLIT plasmid28 to
generate the pC4-RHE-DrPAS. Then, the DrPAS-FRB encoding fragment was cut
out with EcoRI and BamHI and inserted into the multiple cloning site of the
pIRES2-EGFP plasmid (Takara/Clontech) to generate the ﬁnal pIRES2-EGFP-
DrPAS-FRB, which bears the neomycin resistance. The resulting plasmid allows
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Fig. 8 Longitudinal imaging of PPIs in a tumor and monitoring of tumor metastases in a mouse liver. Approximately 1 × 106 MTLn3 cells expressing DrSplit
were injected into the mouse liver. The mice (n= 4) were imaged at multiple time points after tumor cell injection, and rapamycin was injected via the tail
vein ~40–44 h before each PA imaging. a–d PA images of the mouse on a day 5, b day 15, c day 24, and d day 33 after injection of tumor cells, where the
white arrows indicate the secondary tumor. LIR images are overlaid on the anatomical images. The overlay image shows the DrSplit signal in color and the
background blood signal in gray. Scale bar, 5 mm. e Tumor growth curve, in-plane tumor area vs. time (quantiﬁed from LIR images). Error bars represent
s.e.m. for results from four animals. f A representative H&E histological image of a harvested left lobe of a tumorous liver, showing the tumor metastasis,
where the primary tumor and secondary tumor are bordered by green and yellow lines, respectively. Scale bar, 1 mm. The close-up H&E image shows the
secondary tumor, which can be clearly differentiated from normal tissue. Scale bar, 100 µm
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co-expression of DrPAS-FRB and EGFP proteins from the same bicistronic mRNA.
DrGAF-PHY encoding DNA fragment was PCR ampliﬁed as a SpeI-SpeI fragment
and cloned into the iSPLIT plasmid to generate pC4EN-F-DrGAF-PHY. Then
FKBP-DrGAF-PHY encoding fragment was ampliﬁed without an NLS-signal and
inserted as a NheI-KpnI fragment into the pAcGFP1-Hyg-N1 plasmid (Takara/
Clontech). AcGFP1 gene was cut out using BamHI and NotI enzymes and swapped
with IRES2-mCherry, which was a fragment of the pIRES2-mCherry plasmid
(Takara/Clontech). The ﬁnal pIRES2-mCherry-FKBP-DrGAF-PHY plasmid bears
the hygromycin resistance. The resulting plasmid allows co-expression of FKBP-
DrGAF-PHY and mCherry proteins from the same bicistronic mRNA.
For bacterial expression, the PCM encoding part of the DrBphP gene was cloned
into a pBAD/HisB vector (Life Technologies/Invitrogen).
Protein expression and characterization. LMG194 host cells (Life Technologies/
Invitrogen) were used for protein expression. A pWA23h plasmid encoding HO
from Bradyrhizobium ORS278 (hmuO) under the rhamnose promoter was co-
transformed with a pBAD/HisB plasmid encoding DrBphP-PCM with a poly-
histidine tag. The bacterial cells were grown in RM medium supplemented with
ampicillin, kanamycin, and 0.02% rhamnose at 37 °C for 6–8 h, followed by
induction of protein expression by adding 0.002% arabinose and incubation for 24
h at 18 °C. The protein was puriﬁed with Ni-NTA agarose (Qiagen). The sample
was desalted using PD-10 columns (GE Healthcare).
Absorption spectra of DrBphP-PCM, dissolved in phosphate-buffered saline,
were measured using a standard spectrophotometer (Hitachi U-2000) with a 100 µl
quartz microcuvette (Starna Cells). The spectrum of the Pr state (OFF state)
DrBphP-PCM was measured without a photoswitching light source, because the
OFF state was the ground state. To measure the ON state spectra, we carried out
photoswitching with a 636/20 nm custom-assembled LED source placed above the
microcuvette. The photoswitching beam direction was orthogonal to the optical
beam path of the spectrophotometer. The ON state spectra were measured after the
photoswitching was completed and the LED was turned off, so there was no
interference with the measurements. Because of the extremely low-light intensity
(<1 μWcm−2), changes in the absorption spectra of DrBphP-PCM induced by the
light illumination inside the spectrophotometer were negligible. The
photoswitching of DrBphP-PCM shown in Fig. 1d was performed with 780/20-nm
and 636/20-nm LEDs, which were mounted orthogonally to the optical beam path
of the spectrophotometer to avoid detection interference. DrBphP-PCM was
photoswitched directly in the microcuvette of the spectrophotometer while its
absorbance at 780 nm was measured.
FluoroMax-3 spectroﬂuorometer (Jobin Yvon) was used for recording
ﬂuorescence spectra. The photoswitching of the DrBphP-PCM and DrSplit
ﬂuorescence signals in cell lysates shown in Fig. 7d, e, respectively, was performed
with 780/20-nm and 636/20-nm custom-assembled LED arrays. Cell lysates of
HeLa cells transiently transfected with either DrBphP-PCM or DrSplit were
obtained by disruption of cells by freezing-thawing. DrBphP-PCM or DrSplit were
photoswitched directly in the 150 μL quartz microcuvette (Starna Cells) of the
spectroﬂuorometer while its ﬂuorescence at 720 nm was being measured.
Mammalian cell culture. HeLa cells (ATCC, Cat#CCL-2) were grown in DMEM
supplemented with 10% FBS, a penicillin-streptomycin mixture and 2 mM of
glutamine (all from Invitrogen/Life Technologies) at 37 °C in 5% CO2 air atmo-
sphere. To compare expression level of RpBphP1 and DrBphP-PCM HeLa cells
were transiently transfected with RpBphP1-T2A-EGFP or DrBphP-PCM-T2A-
EGFP using an Effectene (Qiagen) according to the manufacturer's protocol.
Expression level of EGFP co-expressed downstream of T2A peptide with RpBphP1
or DrBphP-PCM cells was measured using a LSRII ﬂow cytometer (BD Bios-
ciences) equipped with a 488-nm laser and a 530/40-nm emission ﬁlter. To study
the expression of RpBphP1 and DrBphP-PCM, HEK-293 cells (ATCC, Cat#CRL-
1573) were transiently transfected with RpBphP1-T2A-DrBphP-PCM using
Lipofecteamin 2000 (Invitrogen) according to the manufacturer’s protocol.
U87 cells (ATCC, Cat#HTB-14) were grown in DMEM supplemented with 10%
FBS, a penicillin-streptomycin mixture and 2 mM of glutamine (all from
Invitrogen/Life Technologies) at 37 °C in 5% CO2 air atmosphere. We obtained a
U87 stable preclonal mixture by transfecting cells with pIRES2-mCherry-DrBphP-
PCM plasmid. Plasmid transfection was performed using an Effectene (Qiagen).
Cells were further selected with 75 µg ml−1 of Hygromycin B (Gold Biotechnology)
and enriched using a FACSAria sorter (BD Biosciences) equipped with a 561-nm
laser and a 610/20-nm emission ﬁlter. For further culturing of U87 cells stably
expressing DrBphP-PCM, the medium was supplemented with 75 µg ml−1 of
Hygromycin B.
MTLn3 cells (kindly provided by Dr. J. E. Segall, Albert Einstein College of
Medicine) were grown in MEM Alpha supplemented with 5% FBS, a penicillin-
streptomycin mixture, and 2 mM of glutamine (all from Life Technologies) at 37 °C
in a 5% CO2 air atmosphere. The MTLn3 preclonal mixture was obtained by
transfecting with DrSplit plasmids, pIRES2-EGFP-DrPAS-FRB, and pIRES2-
mCherry-FKBP-DrGAF-PHY. Plasmid transfection was performed using an
Effectene (Qiagen). Cells were further selected with 700 µg ml−1 of G418 (Corning)
and 300 µg ml−1 of Hygromycin B (Gold Biotechnology) and enriched using a
FACSAria sorter (BD Biosciences) equipped with a 488-nm laser with a 530/30-nm
emission ﬁlter and a 561-nm laser with a 610/20-nm emission ﬁlter. After a week of
growth, MTLn3 cells expressing DrSplit were then enriched again using a
FACSAria sorter (BD Biosciences) equipped with a 635-nm laser with a 720/40-nm
emission ﬁlter. Before the second enrichment, the MTLn3 cells with DrSplit were
treated with rapamycin for 24 h. For further culturing of MTLn3 cells stably
expressing DrSplit, the medium was supplemented with 700 µg ml−1 of G418 and
300 µg ml−1 of Hygromycin B.
For induction of the FRB-FKBP protein–protein interaction in cultured cells,
rapamycin (LC Laboratories) was dissolved in ethanol and 100 nM was added to
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Fig. 9 In vivo monitoring of PPIs in a mouse liver after hydrodynamic transfection. a PA image of the mouse liver 24 h after hydrodynamic transfection,
without induction with rapamycin. The LIR image was overlaid on the anatomical images, but no photoswitching signal was detected. Scale bar, 5 mm. b PA
image of the mouse liver 42 h after rapamycin injection, with the LIR image overlaid on the anatomical image. c Ex vivo PA image (ON state) of the liver
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cells 22–25 h before analysis. The cells are analyzed by ﬂuorescence spectroscopy or
ﬂow cytometry in 48 h after transfection.
To test the cytotoxicity of DrSplit, either HeLa or U87 cells were transiently
transfected with pIRES2-EGFP-DrPAS-FRB and pIRES2-mCherry-FKBP-DrGAF-
PHY using Lipofecteamin 2000 (Invitrogen) according to the manufacturer’s
protocol. After 72 h of expression, the ﬂuorescence intensity of EGFP and mCherry
was analyzed by ﬂow cytometry using an LSRII analyzer (BD Biosciences)
equipped with a 488-nm laser with a 530/30-nm emission ﬁlter and a 561-nm laser
with a 610/20-nm emission ﬁlter.
Preparation of animals. Adult 2- to 3-month-old female nude mice (Hsd:Athymic
Nude-FoxlNU, Harlan; body weight: ~20−30 g) were used for all in vivo experi-
ments. All experimental procedures were carried out in conformity with laboratory
animal protocols approved by the Animal Studies Committee at Washington
University in St. Louis and the Ofﬁce of Laboratory Animal Resources at California
Institute of Technology. Throughout the experiment, the mouse was maintained
under anesthesia with 1.5% vaporized isoﬂurane. The anesthetized mouse was
taped to a lab-made motorized animal holder, which held the animal upright
during imaging. The top of the holder was a small aluminum tube, providing
anesthetic gas to the mouse, afﬁxed to the animal’s nose and mouth, and the
bottom was an aluminum cylinder attached to a permanent magnet. The magnet
securely held the animal holder to the scanning stage for elevational scanning. The
animal’s fore and hind legs were taped to the top and bottom parts of the holder,
respectively. The two parts were connected by four lengths of 4-lb test braided
ﬁshing line (0.13 mm in diameter). The animal’s trunk was immersed in water, and
its body temperature was maintained at 34 °C by circulating water through a heated
bath outside the tank.
To implant xenograph tumors into the mice liver, ~106 U87 cells, stably
expressing DrSplit, DrBphP-PCM, RpBphP1 or un-modiﬁed, in 0.05 ml PBS were
injected into mice with the guidance of a Vevo LAZR ultrasound system
(Visualsonics) with a MS550D linear transducer array (Visualsonics; 40 MHz
central frequency, 55% two-way bandwidth).
For induction of FKBP-FRB protein–protein interaction in vivo rapamycin was
used. Rapamycin (LC Laboratories) was dissolved in ethanol to the concentration
of 9 mgml−1. Before its intraperitoneal injection, the concentrated stock of
rapamycin was diluted in an aqueous solution of 5.2% Tween 80 and 5.2% PEG400.
The injected volume was 150 µl and resulted in 4.5 mg kg−1 concentration.
For hydrodynamic transfection, 25 µg of each DrPAS-FRB and FKBP-DrGAF-
PHY, or 25 µg DrBphP-PCM plasmids were diluted in PBS in a volume of 1 ml
10 g–1 body weight and injected rapidly (5–7 s) into the mouse tail vein using a 3 ml
syringe ﬁtted with a 27 gauge needle. Twenty-four hours later, mice were injected
with rapamycin through the tail vein. At 40 h after the rapamycin injection, mice
were anesthetized (isoﬂurane) and imaged using the RS-SIP-PACT system.
Whole-body PACT using DrBphP-PCM and DrSplit. The whole-body PACT
system was upgraded from our previous work2. In order to image DrBphP-PCM
and DrSplit proteins, we combined a Ti:Sapphire laser (LS-2145-LT-150, Sym-
photic Tii, 20 Hz pulse repetition rate, 12 ns pulse width) and a Spitlight EVO
β optical parametric oscillator (OPO) laser (Innolas Laser GMBH; 100 Hz pulse
repetition rate, 4 ns pulse width). The 780 nm light from the Ti:Sapphire laser was
used for both whole-body PA imaging and switching off DrBphP-PCM or DrSplit
at the same time, while the 630 nm light from the Spitlight OPO laser was used for
switching on the proteins. The ﬂash lamps of the two pump lasers were syn-
chronized, and the two lasers were individually triggered by an FPGA-based
controller (National Instruments; sbRIO9626). The two laser beams were com-
bined by a beam combiner, and their incident ﬂuences in mJ cm−2 were measured
by an optical power meter. The laser beam was ﬁrst homogenized by an EDC-
5optical diffuser (RPC Photonics), and then passed through a 130 ° conical lens
(Delmar Photonics) to form a ring-shaped light pattern. The light was then passed
through a home-made optical condenser to form a ring-shaped light band around
the animal’s trunk. The light incident area was aligned slightly above the acoustic
focal plane to ensure sufﬁcient light diffusion. The width of the light band is
~5 mm, and its diameter was similar to the cross-sectional diameter (~2–3 cm) of a
mouse. The maximum light ﬂuence on the skin of the animal was ~2 mJ cm−2 at
630 nm and ~2 mJ cm−2 at 780 nm, respectively, which were within the American
National Standards Institute safety limit exposures (20 mJ cm−2 at 630 nm at a
10-Hz pulse repetition rate, or 200 mW cm−2; 30 mJ cm−2 at 780 nm at a 10 Hz
pulse repetition rate, or 300 mW cm−2)35.
The PA signals were detected by a 512-element full-ring ultrasonic transducer
array (Imasonic; 50 mm ring radius, 5 MHz central frequency, more than 90% one-
way bandwidth). Each element (0.2 acoustic numerical aperture, 20 mm element
height, 0.61 mm pitch, 0.1 mm inter-element spacing) was cylindrically focused.
The combined foci of all 512 elements form an approximately uniform imaging
region with a ~20 mm diameter and 1 mm thickness. Within this region, the in-
plane resolution was ~125 µm and the elevational resolution was ~1 mm
(Supplementary Figure 2). A lab-made 512-channel 26 dB gain pre-ampliﬁer was
directly connected to the ultrasonic transducer array housing, with minimized
connection cable length to reduce cable noise. The pre-ampliﬁed PA signals were
digitized in parallel by a 512-channel data acquisition (DAQ) system (four
SonixDAQs, Ultrasonix Medical ULC; 128 channels each, 40 MHz sampling rate,
12-bit dynamic range) with programmable ampliﬁcation up to 51 dB. For image
reconstruction, the raw data from each element were ﬁrst deconvolved using the
Wiener ﬁlter to account for the ultrasonic transducer’s impulse response, and then
reconstructed within each imaging plane. To mitigate the artifacts induced by
acoustic heterogeneities in the animal body, a half-time, dual-speed-of-sound
variant of the universal back-projection algorithm2,43 was applied for
reconstruction.
The CNR of the reconstructed image was calculated as the peak-to-peak PA
amplitude in the region of interest (ROI), divided by two times the standard
deviation of the background amplitude.
Temporal frequency lock-in reconstruction. Thanks to the high-imaging speed
of the current system, we were able to capture the entire switching process of the
BphPs, which enabled temporal frequency analysis of each pixel. We extracted the
amplitudes of the harmonics of the preset switching frequency (illumination
modulation frequency). The highest-order harmonic was determined empirically
by maximizing the CNR on the reconstructed images. This LIR method demon-
strated a superior CNR over the previous differential method (Supplementary
Figures 4 and 6) with the same number of switching cycles, because it averaged
over the entire decay process within a cycle as well as across different cycles. The
direct differential method, moreover, completely ignores the repeatability of the
decay process across cycles. Typically, a threshold level of four times the noise level,
estimated as the standard deviation of the background signal outside the imaged
region, is globally applied to the temporal frequency domain of reconstructed PA
images. To minimize the inﬂuence of respiratory motion, a non-rigid image
matching algorithm44 was applied to the whole-body image for registration. During
registration, we ﬁrst selected a series of frames where respiratory motions were not
obvious, and then averaged them to a single frame as a reference image. The other
frames were registered to the reference image through a non-rigid image matching
method.
Calculation of decay constant. To quantify the decay constant of the switching
process, raw data from multiple trials were acquired and averaged, and a sequence
of PA images representing one complete decay cycle was reconstructed from the
averaged data. Each PA image was smoothed by a 5-pixel-by-5-pixel square kernel
to further increase the signal-to-noise ratio. The time sequence at each pixel was
then ﬁtted to an exponential decay function of the form f tð Þ ¼ aþ b  e tTð Þ, where
t is the time, f(t) is the measured pixel value at time t, a is the ﬁtted signal baseline,
b is the ﬁtted peak pixel value, and T is the ﬁtted, non-negative time constant.
When two BphPs are fully mixed in a ﬁxed ratio inside cells, the decay function
can be expressed in the form g tð Þ ¼ aþ b  e tT1
 
þ c  e tT2
 
, where T1 > T2.
Generally speaking, the absolute values of all parameters are related to the optical
ﬂuence, especially T1 and T2. Because the 1/e optical penetration depth for NIR
light is far greater than the voxel length, we can assume that the local ﬂuence is
uniform within that voxel. Assuming that the decay rates of both phytochromes are
inﬂuenced by the local ﬂuence in the same way, the ratio R= T1/T2 should be
relatively stable. This hypothesis was supported by our experimental results, where
R was measured to be 2.2–3.0. The ratio k ¼ maxfb;cgminfb;cg should also be stable, because
two phytochromes were mixed in a ﬁxed ratio. Inside HEK-293 cells, the two
phytochromes were expressed in equimolar concentrations. Indeed, the
experimental results for HEK-293 cells showed that b ≈ c ≈ 0.5, and thus k ≈ 1.
Notice that g(t) has a more general form than f(t), thus g(t) could also be used to
ﬁt the decay curve of a single phytochrome, such as DrBphP-PCM only.
Experimental results showed that k was much greater than 1 when only DrBphP-
PCM was measured. Thus, k ¼ maxfb;cgminfb;cg was used as a criterion to distinguish the
two types of cells—HEK-293 cells expressing both DrBphP-PCM and RpBphP1,
and U87 cells expressing only DrBphP-PCM. Empirically, we determined that
when 1 < k < 1.2, the signals were from HEK-293 cells, and when k > 10, the signals
were from U87 cells. This criterion is independent of local optical ﬂuence. To avoid
inﬁnity in computation, the upper limit of k was set to 50. During computation, a
pixel-wise curve ﬁtting operation was performed ﬁrst. Then, we spatially averaged
pixel values of k across the regions of interest, which were deﬁned using the LIR.
If the two types of cells—HEK-293 cells and U87 cells—are mixed together and
cannot be spatially separated, we can use s ¼ k1kþ1 to quantify the concentration of
U87 cells, and thus s′ ¼ 1 s denotes the concentration of HEK-293 cells.
Hematoxylin and eosin histology and ﬂuorescence imaging. The tumor-bearing
livers and kidneys and hydrodynamic-transfected livers were harvested and ﬁxed in
4% paraformaldehyde for 24 h. After parafﬁn embedding, coronal sections (5 µm
thick) of the livers were cut. Standard hematoxylin and eosin (H&E) staining was
performed on the sections, which were examined using bright-ﬁeld microscopy
(NanoZoomer, Hamamatsu) with a 20 × 0.67 NA objective lens.
A lab-made ﬂuorescence imager, including a CCD camera (DV412-BV, Andor)
and camera lens (SP 272E, Tamron, 90 mm, F/2.8), was used for ﬂuorescence
imaging. A laser diode (HL6738MG, Thorlabs Inc., 690 nm, 30 mW) was used for
excitation, and a bandpass ﬁlter (FB750-40, Thorlabs Inc. 750 nm, FWHM= 40 ±
8 nm) was used as an emission ﬁlter. A near-infrared LED (M780LP1, Thorlabs
Inc., 780 nm, 800 mW) was used to switch the DrBphP-PCM/DrSplit proteins to
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Pr state, and a red LED (M625L3, Thorlabs Inc., 625 nm, 700 mW) was used to
switch the proteins to Pfr state.
Reproducibility. The experiments were not randomized. The investigators were
not blinded to allocation during the experiments and outcome assessment. No
sample-size estimation was performed to ensure adequate power to detect a pre-
speciﬁed effect size.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors on reasonable request. The reconstruction algo-
rithm and data processing methods are described in detail in the Methods. We have
opted not to make the data acquisition, image reconstruction, and processing code
available because the code is proprietary and used for other projects.
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